2026 NPPES data Procedural Dermatology Physician NPI 1447201850 M.D.
Verify on CMS →

MICHAEL BIGBY, M.D.

Procedural Dermatology Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
456
Medicare Part D claims · 177 beneficiaries · Procedural Dermatology Physician avg: 664
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$11.9K
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL BIGBY, M.D. is a Procedural Dermatology Physician ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 456 claims across 177 beneficiaries — 9% brand-name prescribing . Industry payments of $11.9K across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL BIGBY, M.D. filed 456 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MICHAEL BIGBY, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MICHAEL BIGBY, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/12/2006

NPI 1447201850

Primary specialty

Procedural Dermatology Physician

Niche

679 US NPIs in this specialty

Medicare Part D claims

456 31% vs specialty avg

2023 prescription claims

Specialty avg: 664

Specialty distribution in Massachusetts

How Procedural Dermatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Procedural Dermatology Physician share within Massachusetts

1. Procedural Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Procedural Dermatology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Procedural Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Procedural Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Procedural Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Procedural Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL BIGBY, M.D. is a Procedural Dermatology Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1447201850. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL BIGBY, M.D. appears in the CMS NPPES registry as a Procedural Dermatology Physician provider holding M.D. credentials at 330 BROOKLINE AVE, BOSTON, MA, 02215, with a listed phone of (617) 667-3753. NPI 1447201850 was issued on 05/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BIGBY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 456 prescription claims written by this provider, covering 177 Medicare beneficiaries and totaling roughly $304K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Procedural Dermatology Physician is a narrow specialty nationwide, with 679 enrolled providers across 48 states and an average of 664 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

330 BROOKLINE AVE
BOSTON, MA 02215

Provider Details

NPI 1447201850
Specialty Procedural Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 05/12/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL BIGBY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$11.9K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MICHAEL BIGBY, M.D.. To verify MICHAEL BIGBY, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHAEL BIGBY, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 456 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

456
Total Claims
$304K
Total Drug Cost
177
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
577
Total Day Supply
16,343
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$283K
Generic Drug Cost
$22K
Antibiotic Claims
42

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.00
Gender Split
47% female / 53% male
Age Distribution
<65: 21, 65-74: 77, 75-84: 63, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
81
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
45
Betamethasone Dipropionate
40
Clobetasol Propionate
30
Triamcinolone Acetonide
27
Fluorouracil
26
Metronidazole
22
Doxycycline Hyclate
15
Econazole Nitrate
14
Clindamycin Phosphate
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Procedural Dermatology Physician Overview

How MICHAEL BIGBY, M.D. fits within the Procedural Dermatology Physician landscape nationally.

679
Procedural Dermatology Physician Providers in US
48
States with Procedural Dermatology Physician
664
Avg Claims per Provider

MICHAEL BIGBY, M.D.'s 456 claims are below the specialty average of 664.

Nearby Procedural Dermatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BIGBY.

Compare Procedural Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL BIGBY, M.D.'s specialty?
MICHAEL BIGBY, M.D. specializes in Procedural Dermatology Physician and practices in BOSTON, Massachusetts. Credentials: M.D..
How much does MICHAEL BIGBY, M.D. prescribe under Medicare Part D?
In 2023, MICHAEL BIGBY, M.D. wrote 456 Medicare Part D claims totaling $304K in drug costs for 177 beneficiaries.
Where is MICHAEL BIGBY, M.D. located?
MICHAEL BIGBY, M.D. is located at 330 BROOKLINE AVE, BOSTON, MA, 02215. Phone: (617) 667-3753.
What is MICHAEL BIGBY, M.D.'s NPI number?
MICHAEL BIGBY, M.D.'s National Provider Identifier (NPI) is 1447201850, issued on 05/12/2006.
Does MICHAEL BIGBY, M.D. prescribe more brand-name or generic drugs?
MICHAEL BIGBY, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $283K in brand drug costs.
How many Procedural Dermatology Physician providers are there in the US?
There are 679 Procedural Dermatology Physician providers across 48 states in the US. The average Procedural Dermatology Physician provider writes 664 Medicare Part D claims per year.
What drugs does MICHAEL BIGBY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL BIGBY, M.D.'s most frequently prescribed drugs include Ketoconazole, Betamethasone Diprop Augmented, Betamethasone Dipropionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL BIGBY, M.D. accept Medicare?
MICHAEL BIGBY, M.D. appears in CMS Medicare data with 456 Part D claims and 177 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL BIGBY, M.D.'s credentials?
MICHAEL BIGBY, M.D.'s NPI is 1447201850 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology